The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysis. [PDF]
HepatologyCullaro G +5 more
europepmc +1 more source
Protective effect of long-chain polyunsaturated fatty acids on hepatorenal syndrome in rats. [PDF]
World J NephrolDuailibe JBB +4 more
europepmc +1 more source
Comparison of hepatorenal syndrome incidence and outcomes using previous and current diagnostic criteria in cirrhotic patients. [PDF]
Hepatol ForumAkbas MM +3 more
europepmc +1 more source
Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis. [PDF]
Front PharmacolWan YM +5 more
europepmc +1 more source
Development and validation of a risk prediction model for hepatorenal syndrome in hepatic failure patients based on glucose-6-phosphate dehydrogenase and hepatic and renal function biochemical parameters. [PDF]
J Med BiochemLiu H +5 more
europepmc +1 more source
Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome. [PDF]
Cochrane Database Syst RevGonzalez-Garay AG +4 more
europepmc +1 more source
Related searches:
Hepatorenal syndrome (HRS) is a form of kidney function impairment that characteristically occurs in cirrhosis. Recent changes in terminology have led to acute HRS being referred to as acute kidney injury (AKI)-HRS and chronic HRS as chronic kidney disease (CKD)-HRS.
Elsa Sola +2 more
exaly +7 more sources
Development of acute kidney injury in patients with chronic liver disease is common and portends a poor prognosis. Diagnosis remains challenging, as traditional markers, such as serum creatinine, are not reliable. Recent development of novel biomarkers may assist with this.
Saro, Khemichian +4 more
openaire +2 more sources